Passa al contenuto
Merck

Effect of phencyclidine derivatives on anxiety-like behavior using an elevated-plus maze test in mice.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University (2012-12-12)
Ramin Hajikhani, Abbas Ahmadi, Nima Naderi, Kayvan Yaghoobi, Zahra Shirazizand, Nazereh M Rezaee, Babak N Niknafs
ABSTRACT

The study attempted to investigate the anti-anxiety activities of Phencyclidine (1-(1-phenylcyclohexyl) piperidine, PCP, I) and some of its derivatives (M, F, L, B, S, P) with the elevated-plus maze (EPM) Test. Phencyclidine and its derivatives (M, F, L, B, S, P) were administrated intraperitoneally (i.p.) at a dose of 10 mg/kg to male mice. Anxiety-like behaviors were assessed using the elevated-plus maze test. EPM results revealed an increase in open arms time spent after applying PCP and M, L, P, and B compounds at the administered dosage. Moreover, an increase in the number of open arm entries was observed with M, P, and B compounds. The P, B and S compounds increased the locomotion of animals, too, which might be considered as the side effect to the compounds. Considering the elevated-plus maze results, it was concluded that M and L compounds could be considered as a potential anxiolytic with less side effects due to a probable high electron donation of the methoxy group, as well as the hydrophilic properties of hydroxyl groups on these compounds.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Supelco
PCP (Phencyclidine) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®